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Purpose: Dexmedetomidine, a potent selective α2-adrenergic agonist, produces 
sedation and analgesia. This study was conducted to assess the effect of dexme-
detomidine infusion on sevoflurane requirements, recovery profiles, and emer-
gence agitation in children undergoing ambulatory surgery. Materials and Meth-
ods: Forty children undergoing ambulatory hernioplasty or orchiopexy were 
randomized into two groups. The dexmedetomidine group (Group D, n=20) re-
ceived dexmedetomidine 1 μg/kg, followed by 0.1 μg/kg/h until the end of sur-
gery, whereas the saline group (Group S, n=20) received volume-matched normal 
saline. Sevoflurane was used for induction and maintenance of anesthesia and cau-
dal block was performed in all children. End-tidal sevoflurane concentration (ET-
sevo), the incidence of emergence agitation, pain scores, and sedation scores were 
recorded. Hemodynamic changes and other adverse effects were assessed in the 
perioperative period. Results: ET-sevo of Group D was significantly reduced in 
23.8-67% compared to Group S during surgery. The incidence of emergence agita-
tion was lower in Group D than in Group S (5% vs. 55%, p=0.001). Postoperative 
pain was comparable, and discharge time was not different between the groups. 
Mean arterial pressure and heart rate were significantly lower in Group D during 
surgery. Conclusion: Intraoperative infusion of dexmedetomidine reduced sevo-
flurane requirements and decreased emergence agitation without delaying dis-
charge in children undergoing ambulatory surgery. However, caution should be 
taken in regard to bradycardia and hypotension.
Key Words:   Agitation, ambulatory surgery, dexmedetomidine, emergence, sevo-
flurane
INTRODUCTION
Dexmedetomidine, a potent selective α2-adrenergic agonist, is frequently used off-
label in children because of its efficacy and lack of respiratory depression.1,2 Be-
cause dexmedetomidine has sedative, hypnotic and analgesic properties, it can re-
duce the dose of hypnotics, opioids, analgesics, and anesthetics required to be 
concomitantly administered.3 Intraoperative administration of dexmedetomidine 
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dren lost consciousness. Anesthesia was induced via a face-
mask with 6-7% sevoflurane in oxygen at a gas flow of 4 L/
min. The induction scale was assessed based upon mask ac-
ceptance (1=accept mask readily; 2=slight fear of mask, eas-
ily calmed; 3=not calmed with reassurance; 4=terrified, cry-
ing, agitated).19 A scale score of 1 or 2 was considered to be 
satisfactory induction. After the loss of consciousness, intra-
venous access was achieved. The coded drug was accord-
ingly given to each group by the blinded anesthetic practi-
tioner. The drug of 1 μg/kg was administered intravenously 
over 10 min using a syringe pump, followed by a 0.1 μg/kg/
h infusion until the end of surgery in both groups. In Group 
S, the same amount of saline was administered in an identi-
cal sequence. When the bispectral index (BIS) score reached 
40, the laryngeal mask airway (LMA) was inserted. A cau-
dal block was then performed with 1.3 mL/kg of 0.2% ropi-
vacaine (maximum volume, 20 mL) in both groups. Success-
ful drug injection within the caudal space was routinely 
confirmed with ultrasound. As soon as caudal block was 
done, the operation was started. Anesthesia was maintained 
by adjusting the end-tidal concentration of sevoflurane (ET-
sevo) to achieve a BIS score of 45-50 during surgery. Dur-
ing operation, no additional analgesics were given. Respira-
tion was maintained spontaneously throughout the 
operation. When skin suture was started, sevoflurane and 
dexmedetomidine or saline administrations were discontin-
ued. All patients were kept breathing spontaneously through-
out the surgery. The LMA was removed when the patients 
opened their eyes spontaneously or moved when their chins 
were lifted. Time to LMA removal was defined as the time 
interval from ‘end of operation’ to ‘LMA removal’ and re-
garded as the time to awake.
ET-sevo, mean arterial pressure (MAP), and heart rate 
(HR) were recorded just before dexmedetomidine adminis-
tration (T0, baseline), just after dexmedetomidine loading of 
1 μg/kg (T1), 10 min after dexmedetomidine loading (T2), 
start of operation (T3), 10, 20, 30 min after the start of opera-
tion (T4, T5, T6), and at the end of operation (T7). Atropine 
0.01 mg/kg was administered during the procedure when the 
HR decreased >30% of baseline value (T0). The patients 
were monitored in the post-anesthetic care unit (PACU) by a 
nurse and their parents, both of whom were blinded to the 
child’s group allocation. Because most of the EA episodes 
occurred within 30 min of PACU arrival,13,18,20 EA was as-
sessed at arrival and every 5 min for up to 30 min in PACU. 
EA was rated using a four-point scale modified by Watcha, 
et al.21 (1=calm, 2=crying, but can be consoled, 3=crying and 
reduced sevoflurane requirements in children undergoing 
various surgeries.4-6  
Emergence agitation (EA) occurs frequently in children 
during recovery from anesthesia. The etiology of EA in-
cludes multiple factors, such as pain, anxiety, surgical type, 
personal character, rapid awakening, and anesthetic type, and 
sevoflurane has been considered to cause a higher incidence 
of EA than other anesthetics in pediatric patients.7-9 The inci-
dence of EA under sevoflurane anesthesia varies from 10 to 
70% depending on the definition of EA.4,10-13  Several preven-
tative strategies have been investigated for EA under sevoflu-
rane anesthesia in children.14-16 Also, intraoperative adminis-
tration of dexmedetomidine has shown to effectively reduce 
EA in children because of its anxiolytic and analgesic proper-
ties without respiratory depression.4,12,13,17,18
In this randomized double blind study, we hypothesized 
that intraoperative use of dexmedetomidine would reduce 
sevoflurane requirements in children undergoing ambulato-
ry surgery. Furthermore, we evaluated the effects of dexme-
detomidine on recovery profiles and EA.
MATERIALS AND METHODS
　　　
The study was approved by the Institutional Review Board 
of Severance Hospital (IRB number: 4-2011-0430) and 
registered to the www.ClinicalTrials.gov (NCT01691001). 
After obtaining written informed consent from parents, 40 
children, ASA 1, aged 1-5 years (≤20 kg) who were under-
going ambulatory hernioplasty or orchiopexy were enrolled 
in this study. Children with mental retardation, develop-
mental delay, neurological or psychiatric illnesses that may 
be associated with agitation, coagulation disorder, spinal 
anomalies, or bilateral procedures were excluded. 
The patients were randomly assigned to two groups; those 
who received dexmedetomidine (Group D, n=20) or saline 
(Group S, n=20) using a computer-generated randomiza-
tion. Drugs used in the study were prepared in an anesthesia 
preparation room and coded as A or B by a nurse who was 
blinded to the study. For Group D, dexmedetomidine (Pre-
cedexTM, Hospira Worldwide, Lake Forest, IL, USA) was 
mixed in normal saline to make 1 μg/mL in a 50 mL syringe. 
For Group S, normal saline was also prepared in a 50 mL sy-
ringe, and no premedication was given. To reduce preoper-
ative anxiety, the children were moved to the operating 
room while watching an animated movie with their parents, 
and the parents remained next to the children until the chil-
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sures analysis of variance was performed to compare repeated 
measure variables (ET-sevo, MAP, and HR) with a Bonferro-
ni correction for multiple comparisons. Data are presented as 
mean±SD, median (range) and number. A p-value <0.05 was 
considered statistically significant.
RESULTS
 
Of a total of 47 patients assessed for eligibility, 40 subjects 
received dexmedetomidine or saline after randomization and 
none were eliminated from the data collection (Fig. 1).                  
No differences were seen in demographics and anesthetic 
characteristics between the two groups (Table 1). As shown 
in Fig. 2, ET-sevo was significantly lower in Group D than 
in  Group S after dexmedetomidine administration; ET-sevo 
reduced by 60% (±10) in Group D compared to Group S.
The incidence of EA was lower in Group D than in Group 
S (5% vs. 55%, p=0.001) and agitation scores were signifi-
cantly lower in Group D than in Group S during the first 20 
min after PACU arrival (Table 2). 
Pain scores were comparable in the two groups except at 
cannot be consoled, 4=agitated and thrashing around). If a 
child fell asleep, this was defined as a score of 0. Children 
with scores of 3 or 4 were considered to have had an EA epi-
sode. Postoperative pain was assessed with the Children’s 
Hospital of Eastern Ontario Pain Scale (CHEOPS)22 and the 
Face, Legs, Activity, Cry, Consolability scale (FLACC)23 
upon PACU arrival, at 30 min, 60 min, and 120 min post-
operatively. When children showed CHEOPS or FLACC 
scores ≥4, 0.5 μg/kg of fentanyl was administered. Sedation 
level was assessed with the Ramsay’s sedation scale (1= 
anxious and agitated or restless, or both; 2=co-operative, 
oriented, and calm; 3=responsive to commands only; 4= 
exhibiting brisk response to light glabellar tap or loud audi-
tory stimulus; 5=exhibiting a sluggish response to light gla-
bellar tap or loud auditory stimulus; and 6=unresponsive).24 
The first oral intake time and discharge time were recorded, 
and adverse events were also noted. 
Statistical analysis
Sample size calculation was based on previous studies.4,25  In 
these studies, ET-sevo was decreased 33.1% and 41.6% in 
patients who received dexmedetomidine.4,25 If dexmedetomi-
dine infusion can reduce 35% of the ET-sevo, the difference 
of the means of ET-sevo would be 1.0%, and SD would be 
estimated as 1.0%. For an α=0.05 and a power of 80%, 17 
patients were required per group. Therefore, 20 patients were 
included in each group to allow for possible drop-outs. 
Data were analyzed using IBM SPSS Statistics 19TM 
(SPSS Inc., Chicago, IL, USA). The normality of distribution 
was assessed with a Q-Q plot and the Shapiro-Wilk test. 
Parametric data were analysed with the independent t-test, 
and non-parametric data were analyzed using the Mann-
Whitney U test. Categorical data were analyzed using the χ2-
test or Fisher exact tests when appropriate. A repeated mea-
Table 1.  Demographic and Anesthetic Characteristics
Group D 
(n=20)
Group S 
(n=20)
Age (months)    17 (8-35) 16.5 (6-53)
Weight (kg) 11.7 (7.4-15.5) 11.9 (6.6-16.8)
Height (cm)    85 (63-100) 83.5 (62.8-108)
Satisfactory induction 16 15 
Operation time (min) 39±20 44±24
Anesthesia time (min) 64±20 67±22
Time to LMA removal (min) 4 (0-8) 3 (0-9)
D, dexmedetomidine; S, saline; LMA, laryngeal mask airway.
Data are presented as mean±SD, median (range) or number.
Fig. 1. Flow chart representing patient assignment to study groups (randomized) and treatment protocols.
Enrolment
Allocation
Follow-up
Analysis
Excluded (n=7)
    Not meet inclusion criteria (n=4)
    Refused to participate (n=3)
Analysed (n=20) Analysed (n=20)
Assessed for eligibility (n=47)
Allocated to Group D (n=20)
    Received allocated intervention (n=20)
Lost to follow-up (n=0)
    Discontinued intervention (n=0)
Allocated to Group S (n=20)
    Received allocated intervention (n=20)
Lost to follow-up (n=0)
    Discontinued intervention (n=0)
Randomized (n=40)
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related to the anesthesia such as nausea, vomiting, or uri-
nary retention (Table 4).
DISCUSSION
The results of this prospective double-blinded randomized 
study suggest that intraoperative dexmedetomidine infusion 
reduced anesthetic requirements and decreased emergence 
agitation without delaying discharge in children undergoing 
ambulatory surgery. 
Dexmedetomidine is a potent α2-adrenoceptors agonist, 
and presynaptic activation of α2-adrenoceptors in the locus 
ceruleus is responsible for both analgesic and sedative ef-
fect.3,26 Therefore, dexmedetomidine may be an effective 
30 min in PACU. Fentanyl was given in 2 patients of Group 
S for pain control in the PACU (Table 3). Sedation scores 
were significantly higher in Group D than in Group S at the 
time of arrival in the PACU and at 30 min (Table 4). 
The hemodynamic changes are shown in Fig. 3. MAP 
and HR were significantly lower in Group D than in Group 
S; MAP and HR decreased by 22-28% and 18-21% respec-
tively in Group D than Group S. Atropine was administered 
to 6 patients of Group D who showed bradycardia with or 
without hypotension (p=0.020), during the dexmedetomi-
dine load. 
First oral intake and discharge time were not different be-
tween the groups. There were no significant adverse effects 
Table 2. Incidence and Scores of Emergence Agitation in 
the Post-Anesthetic Care Unit
Group D (n=20) Group S (n=20)
Emergence agitation 1* 11
Agitation scores
    PACU arrival 0 (0-2)* 0 (0-4)
    5 min in PACU 0 (0-2)* 1 (0-4)
    10 min in PACU 2 (0-3)* 3 (0-4)
    15 min in PACU 1 (0-3)* 3 (0-3)
    20 min in PACU 1 (1-2)* 2 (1-3)
    25 min in PACU 1 (1-2) 1 (1-2)
    30 min in PACU 1 (1-2) 1 (1-1)
PACU, post-anesthetic care unit; D, dexmedetomidine; S, saline.
Data are presented as median (range) or number. Emergence agitation is 
defined as an agitation score ≥3 during the period of arrival to 30 min in 
PACU. Agitation score: 0=asleep, 1=calm, 2=crying, but can be consoled, 
3=crying and cannot be consoled, 4=agitated and thrashing around. Emer-
gence agitation means agitation scores of 3 or 4. 
*p<0.05 compared with Group S.
Table 3. Postoperative Pain Scales 
Group D (n=20) Group S (n=20)
CHEOPS
    PACU arrival 1 (1-4) 1 (1-5)
    Postoperative 30 min 1 (1-4)* 2 (1-4)
    Postoperative 60 min 1 (0-2) 1 (0-2)
    Postoperative 120 min 1 (0-2) 1 (0-2)
FLACC
    PACU arrival 0 (0-8) 0 (0-6)
    Postoperative 30 min 0 (0-8)* 3 (0-7)
    Postoperative 60 min 0 (0-2) 0 (0-4)
    Postoperative 120 min 0 (0-2) 0 (0-2)
Analgesic administraion 0 2
CHEOPS, Children’s Hospital of Eastern Ontario Pain Scale (appendix 1); 
FLACC, Face, Legs, Activity, Cry, Consolability scale (appendix 2); PACU, 
post-anesthetic care unit; D, dexmedetomidine; S, saline. 
Data are presented as median (range) or number.
*p<0.05 compared with Group S.
Table 4. Postoperative Sedation Scales and Other Recovery 
Profiles
Group D (n=20) Group S (n=20)
Ramsay’s sedation scale
    PACU arrival 5 (1-6)* 3 (1-6)
    Postoperative 30 min 2 (1-4)* 2 (1-3)
    Postoperative 60 min 2 (1-4) 2 (1-3)
    Postoperative 120 min 2 (1-3) 2 (1-3)
Oral intake time (min) 103.5 (43-190)   70 (45-164)
Discharge time (min)    201 (180-270) 207 (150-480)
PACU, post-anesthetic care unit; D, dexmedetomidine; S, saline.
Data are presented as median (range) or number. Ramsay’s sedation scale: 
1=anxious and agitated or restless, or both; 2=co-operative, oriented, and 
calm; 3=responsive to commands only; 4=exhibiting brisk response to light 
glabellar tap or loud auditory stimulus; 5=exhibiting a sluggish response to 
light glabellar tap or loud auditory stimulus; and 6=unresponsive. 
*p<0.05 compared with Group S.
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differ according to the type of surgery in addition to dexme-
detomidine dose, different age of patients and combined ef-
fects of anesthetics or analgesics.3,20,27,28,32,33 
EA is not a new phenomenon, though its prevalence has 
increased with the introduction of sevoflurane, especially in 
pre-school aged children. EA is self-limiting and resolves 
spontaneously, but restless recoveries can result in patient 
injury, surgical site damage and dissatisfaction for patients 
and parents. This characteristic of EA has been attributed to 
several factors such as patient-related (age, anxiety, and tem-
perament), anesthesia-related (rapid emergence, and anes-
thetics), and surgery-related (pain and surgery type).9 In the 
current study, we tried to exclude several possible factors of 
EA such as preoperative anxiety, surgical type, and postop-
erative pain. The incidence of EA has been reported up to 
70% in sevoflurane anesthesia.11 Sevoflurane even causes a 
high incidence of EA in the absence of surgery.9,18 The reason 
for frequent EA after sevoflurane is not clearly understood. 
Nevertheless, sevoflurane in any particular situation may ex-
ert an irritating effect on the central nervous system,34,35 al-
though it was suggested that the type of inhalation agent may 
not be directly correlated with the incidence of EA.36 
In the current study, we found that dexmedetomidine ad-
ministration reduced EA significantly without delaying dis-
charge. A single dose or continuous infusion of dexmedeto-
midine reduces EA after sevoflurane in children.4,12,13 The 
reason for reducing EA is yet unclear, however, the analgesic 
and sedative effects of dexmedetomidine may provide a pro-
tective effect against EA.4,12,13,18 However, in a recent meta-
analysis that evaluated prevention of EA, analgesic proper-
ties did not seem to play a role in preventing EA.37 A recent 
study also suggested that lower incidence of EA could be 
adjuvant during general anesthesia by decreasing the doses 
of anesthetics and analgesics.27-29 The primary end-point of 
this study was the reduction of ET-sevo to maintain a BIS 
score of 45-50 during surgery. To provide adequate anes-
thetic depth, the BIS was kept within 45-50 range in both 
groups. Although it is considered that BIS has low sensitiv-
ity and specificity to assess the anesthetic depth and it may 
be dependent on anesthetics used, it is usual to maintain 
BIS values less than 50 during anesthesia in children.30 
In several studies performed on adults undergoing ab-
dominal surgery, ET-sevo was decreased by 27.3-33% with 
a dexmedetomidine 1 μg/kg bolus and a 0.4-0.6 μg/kg/h in-
fusion.25,29,31 In pediatric tonsillectomy patients, the ET-sevo 
can be reduced up to 41.6% with a dexmedetomidine 2 μg/
kg bolus, followed by 0.7 μg/kg/h infusion when compared 
with intraoperative fentanyl bolus.4 The analgesic-sparing 
effect of dexmedetomidine can be enhanced when using 
N2O.32 Supplemental drugs such as dexamethasone and ac-
etaminophen may affect the additive analgesic interactions 
of dexmedetomidine and sevoflurane.4 In our study, no sup-
plemental drugs or N2O were given during surgery, and the 
ET-sevo of Group D was reduced by 23.8-67% compared 
to Group S, despite the low dose of dexmedetomidine (1 
μg/kg bolus, followed by 0.1 μg/kg/h infusion). 
In previous studies in children, dexmedetomidine infusion 
rate varied (0.2-0.7 μg/kg/h) under sevoflurane anesthe-
sia.1,4,12,17,29 We selected a low infusion rate of dexmedetomi-
dine (0.1 μg/kg/h), because the children were undergoing 
minor urological surgery and supplemental caudal block. 
Inguinal hernioplasty or orchiopexy produce less surgical 
stimulation than other procedures, such as tonsillectomy. 
The anesthetic-sparing effects of dexmedetomidine may 
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related to the lower concentration of sevoflurane.14 The 
combined effects of reduction of sevoflurane and dexme-
detomidine administration might have reduced the inci-
dence of EA in our study. 
Time to LMA removal which is also regarded as the time 
to awake was not different between the two groups. Fur-
thermore, the LMA removal time of Group D was short 
compared to other studies.4,12,38 These different results may 
be due to the low infusion rate of dexmedetomidine and the 
type of surgery (minor urological surgery).
Dexmedetomidine can also cause a variety of hemody-
namic changes in children.1,2,39 The most common hemody-
namic effects of dexmedetomidine are bradycardia and hy-
potension, which are attributed to central α2-agonist proper-
ties.1 Transient hypertension can also be result from perip-
heral α-receptor stimulation.1 In the current study, Group D 
showed significantly lower MAP and HR during operation 
than Group S. Although the hemodynamic changes varied 
according to dose and surgical type, hemodynamic instabil-
ity may occur frequently in minor surgery even if low doses 
of dexmedetomidine are used.1,2,4,12 
The limitation of this study is uncertainty about whether 
we used a proper scoring tool for EA. The pediatric anesthe-
sia emergence delirum scale developed by Sikich and Ler-
man40 is a valid and reliable rating scale, but it may not be ap-
plicable to children who are asleep in the PACU. Therefore, 
we used a scale by Watcha, et al.,21 which includes a consola-
bility component. Although there is a risk of mis-scaling due 
to pain, we excluded the possibility of pain because we 
confirmed successful drug injection within the caudal space 
using ultrasound. In addition, since sample size calculation 
was based on ET-sevo, sample size may not be enough to 
check emergence agitation. Therefore, emergence agitation 
observed in Group D may be underpowered. 
In conclusion, intraoperative dexmedetomidine 1 μg/kg 
bolus, followed by 0.1 μg/kg/h infusion, significantly re-
duced anesthetic requirements and also decreased the inci-
dence of EA during recovery without delaying discharge in 
children undergoing ambulatory surgery.  However, caution 
should be taken because of the side effects including hypo-
tension and bradycardia.
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